The side effects of chemotherapeutic agents

Current Anaesthesia and Critical Care

Volumn 19, Issue 2, 2008, Pages 70-79

  Carr, Craig ^a   Ng, Julia ^a   Wigmore, Tim ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer chemotherapy; Complications cancer

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTHRACYCLINE DERIVATIVE; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BLEOMYCIN; BUSULFAN; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; DEFIBROTIDE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; FLUOROURACIL; FOSCARNET; GEMCITABINE; HEPARIN; INTERFERON; LOPERAMIDE; METHOTREXATE; MITOMYCIN C; MONOCLONAL ANTIBODY; NYSTATIN; PALIFERMIN; PLATINUM COMPLEX; TAXANE DERIVATIVE; TRASTUZUMAB; UNINDEXED DRUG;

ACUTE KIDNEY TUBULE NECROSIS; AMNESIA; ANAPHYLAXIS; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; ASEPTIC MENINGITIS; ATAXIA; AUTONOMIC NEUROPATHY; BONE MARROW SUPPRESSION; BREAST CARCINOMA; BRONCHOSPASM; CANCER RADIOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM DISEASE; CHOLESTASIS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COLITIS; CONFUSION; CONSERVATIVE TREATMENT; CONSTIPATION; CRYOTHERAPY; DIARRHEA; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG FATALITY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG METABOLISM; DRUG OVERDOSE; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEART ARRHYTHMIA; HEART FAILURE; HEART INJURY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC CYSTITIS; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERHIDROSIS; HYPERKALEMIA; HYPERPHOSPHATEMIA; HYPERURICEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; ILEUS; IMMUNE DEFICIENCY; INTENSIVE CARE; INTENSIVE CARE UNIT; INTESTINE PERFORATION; INTESTINE SURGERY; ISCHEMIC COLITIS; KIDNEY DISEASE; KIDNEY TUBULE ACIDOSIS; KIDNEY TUBULE DAMAGE; LEUKOENCEPHALOPATHY; LEUKOPENIA; LIVER DISEASE; LIVER DYSFUNCTION; LIVER VENOOCCLUSIVE DISEASE; LOW LEVEL LASER THERAPY; LUNG FIBROSIS; LUNG INJURY; METABOLIC DISORDER; MOTOR NEUROPATHY; MUCOSA INFLAMMATION; MYCOSIS; MYELITIS; NAUSEA AND VOMITING; NEOPLASM; NEPHROTOXICITY; NEUROLOGIC DISEASE; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; OTOTOXICITY; PERIPHERAL NEUROPATHY; PLASMA OSMOLALITY; PLASMAPHERESIS; PLEURISY; PNEUMONIA; PRIORITY JOURNAL; REHYDRATION; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RISK FACTOR; SEIZURE; SENSORY NEUROPATHY; SIDE EFFECT; SKIN BLEEDING; SYSTEMIC DISEASE; SYSTOLIC DYSFUNCTION; TACHYCARDIA; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR LYSIS SYNDROME; UNSPECIFIED SIDE EFFECT; WATER RETENTION; XEROSTOMIA;

EID: 41149131383     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2008.01.004     Document Type: Article

References (37)

1. Floyd J.D., Nguyen D.T., Lobins R.L., Bashir Q., Doll D.C., and Perry M.C. Cardiotoxicity of cancer therapy. J Clin Oncol 23 30 (2005) 7685-7696
2. Gottdiener J.S., Appelbaum F.R., Ferrans V.J., Deisseroth A., and Ziegler J. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141 6 (1981) 758-763
3. Singal P.K., and Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 339 13 (1998) 900-905
4. Seidman A., Hudis C., Pierri M.K., Shak S., Paton V., Ashby M., et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 20 5 (2002) 1215-1221
5. Perez E.A., Byrne J.A., Hammond I.W., Rafi R., Martin A.M., Berger M.S., et al. Cardiac safety experience in 3127 patients treated with lapatinib (abstr). Ann Oncol 17 Suppl. 9 (2006) ix69 (1420)
6. Saif M.W., Szabo E., Grem J., and Hamilton M. The clinical syndrome of 5-fluorouracil cardiotoxicity (abstr). Proc Am Soc Clin Oncol 20 (2001) 404
7. Rowinsky E.K., McGuire W.P., Guarnieri T., Fisherman J.S., Christian M.C., and Donehower R.C. Cardiac disturbances during the administration of taxol. J Clin Oncol 9 9 (1991) 1704-1712
8. Twohig K.J., and Matthay R.A. Pulmonary effects of cytotoxic agents other than bleomycin. Clin Chest Med 11 1 (1990) 31-54
9. Beinert T., Binder D., Stuschke M., Jörres R.A., Oehm C., Fleischhacker M., et al. Oxidant-induced lung injury in anticancer therapy. Eur J Med Res 4 2 (1999) 43-53
10. Collis C.H. Lung damage from cytotoxic drugs. Cancer Chemother Pharmacol 4 1 (1980) 17-27
11. Sonis S.T., Elting L.S., Keefe D., Peterson D.E., Schubert M., Hauer-Jensen M., et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 Suppl. 9 (2004) 1995-2025
12. Barasch A., and Peterson D.E. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 39 2 (2003) 91-100
13. Pico J.L., Avila-Garavito A., and Naccache P. Mucositis: its occurrence, consequences, and treatment in the oncology setting. The Oncologist 3 6 (1998) 446-451
14. Keefe D.M., Schubert M.M., Elting L.S., Sonis S.T., Epstein J.B., Raber-Durlacher J.E., et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109 5 (2007) 820-831
15. American Society of Clinical Oncology, Kris M.G., Hesketh P.J., Somerfield M.R., Feyer P., Clark-Snow R., et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24 18 (2006) 2932-2947 [Epub 2006 May 22. Erratum in: J Clin Oncol 2006; 24(33):5341-2 [November 20]]
16. http://www.cancer.gov/cancertopics/pdq/supportivecare/gastrointestinalcomplications/HealthProfessional/page5#Section_129
17. Cappell M.S. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol 99 6 (2004) 1175-1190
18. Williams N., and Scott A.D. Neutropenic colitis: a continuing surgical challenge. Br J Surg 84 9 (1997) 1200-1205
19. Buckner F.S., and Pomeroy C. Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 17 4 (1993) 644-656
20. Badgwell BD, Camp ER, Feig B, Wolff RA, Eng C, Ellis LM, et al. Management of bevacizumab-associated bowel perforation: a case series and review of the literature. Ann Oncol 2007 [Epub ahead of print].
21. Levitsky J., and Sorrell M.F. Hepatic complications of hematopoietic cell transplantation. Curr Gastroenterol Rep 9 1 (2007) 60-65
22. Ho V.T., Revta C., and Richardson P.G. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies. Bone Marrow Transpl 41 3 (2008) 229-237
23. Lam M., and Adelstein D.J. Hypomagnesemia and renal magnesium wasting in patients treated with cisplatin. Am J Kidney Dis 8 3 (1986) 164-169
24. Bode U., Seif S.M., and Levine A.S. Studies on the antidiuretic effect of cyclophosphamide: vasopressin release and sodium excretion. Med Pediatr Oncol 8 3 (1980) 295-303
25. Jackson A.M., Rose B.D., Graff L.G., Jacobs J.B., Schwartz J.H., Strauss G.M., et al. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. Ann Intern Med 101 1 (1984) 41-44
26. Schiff D., and Wen P. Central nervous system toxicity from cancer therapies. Hematol Oncol Clin North Am 20 6 (2006) 1377-1398
27. Sul J.K., and Deangelis L.M. Neurologic complications of cancer chemotherapy. Semin Oncol 33 3 (2006) 324-332
28. Genvresse I., Dietzmann A., Massenkeil G., Späth-Schwalbe E., and Possinger K. Subacute encephalopathy after combination chemotherapy including moderate-dose methotrexate in a patient with gastric cancer. Anticancer Drugs 10 3 (1999) 293-294
29. Wendling L.R., Bleyer W.A., Di Chiro G., and McIlvanie S.K. Transient, severe periventricular hypodensity after leukemic prophylaxis with cranial irradiation and intrathecal methotrexate. J Comput Assist Tomogr 2 4 (1978) 502-505
30. Cavaliere R., and Schiff D. Neurologic toxicities of cancer therapies. Curr Neurol Neurosci Rep 6 3 (2006) 218-226
31. Widemann B.C., Balis F.M., Shalabi A., Boron M., O'Brien M., Cole D.E., et al. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. J Natl Cancer Inst 96 20 (2004) 1557-1559
32. Daniel D., and Crawford J. Myelotoxicity from chemotherapy. Semin Oncol 33 1 (2006) 74-85
33. Alavi J.B., Root R.K., Djerassi I., Evans A.E., Gluckman S.J., MacGregor R.R., et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med 296 13 (1977) 706-711
34. Vogler W.R., and Winton E.F. A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 63 4 (1977) 548-555
35. Tiu R.V., Mountantonakis S.E., Dunbar A.J., and Schreiber Jr. M.J. Tumor lysis syndrome. Semin Thromb Hemost 33 4 (2007) 397-407
36. Lenz H.J. Management and preparedness for infusion and hypersensitivity reactions. The Oncologist 12 5 (2007) 601-609
37. Yagoda A., Mukherji B., Young C., Etcubanas E., Lamonte C., Smith J.R., et al. Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients. Ann Intern Med 77 6 (1972) 861-870